ATI Advisory study, supported by AHCA/NCAL, shows correlation between I-SNP enrollment and lower rates of hospitalization, emergency department visits, and...
"As SAM (Smart Approaches To Marijuana) and MMJ International Holdings Prepare an Appeal, Medicare Doctors Now Stand Between Seniors and...
SHELTON, CT / ACCESS Newswire / May 26, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Clinical-Stage Pharmaceutical Developer Says Recent Coverage Misses the Real Story: Marijuana Chemistry, Safety, and Scientific Validation WASHINGTON, D.C. / ACCESS...
TORONTO, May 25, 2026 (GLOBE NEWSWIRE) -- “Get on Board,” the Health Coalition is saying. “Stop Ford’s Privatization Train Wreck!”...
Medicare's Hemp Program Continues Despite Federal Restrictions Taking Effect in Less Than Six MonthsCourt Declines to Address Safety, Legality, or...
ALEXANDRIA, VA / ACCESS Newswire / May 21, 2026 / The American Society of Consultant Pharmacists (ASCP) commends the House...
SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Highlights:WellCare Today brings established RPM, RTM and CCM infrastructure with wearable technology integrations and connected monitoring solutionsCombination expected to integrate...
The federal government just launched a CMS program giving America's seniors access to hemp, marijuana products through Medicare. There's one...
"As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, and Patient Protections" stated...
In SAM et al. v. Kennedy (1:26-cv-01081), the Court Weighs Whether CMS Overstepped Its Authority by allowing Hemp, Marijuana Cannabinoid...
Bombshell lawsuits, a European safety bombshell, and a rogue Medicare program converge in the most dangerous moment in American cannabinoid...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales (recorded by Sanofi) increased...
MMJ International Holdings, an FDA IND-stage pharmaceutical cannabinoid developer, is a plaintiff in landmark litigation before the U.S. District Court...
Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for PatientsNEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands,...
The project will lay the foundation for broader adoption of a core set of quality measures to guide care, accountability,...
The project will lay the foundation for broader adoption of a core set of quality measures to guide care, accountability,...
DENVER, April 21, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in...
MARKHAM, Ontario, April 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results...